144
Views
24
CrossRef citations to date
0
Altmetric
Original Research

The Impact of Vitamins and/or Mineral Supplementation on Blood Pressure in Type 2 Diabetes

, PhD, , PhD, , PhD, , MD & , PhD
Pages 272-279 | Received 07 Jun 2003, Accepted 12 Feb 2004, Published online: 19 Jun 2013

REFERENCES

  • Kirpichnikov D, Sowers JR: Role of ACE inhibitors in treating hypertensive diabetic patients. Curr Diab Rep2 :251– 257,2002 .
  • American Diabetes Association: Treatment of hypertension in adults with diabetes. Diabetes Care26 :S80– S82,2003 .
  • Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: The Framingham Study. Circulation59 :8– 13,1979 .
  • Mehler PS, Jeffers BW, Estacio R, Schrier RW: Associations of hypertension and complications in non-insulin-dependent diabetes mellitus. Am J Hypertens10 :152– 161,1997 .
  • Wan Nazaimoon WM, Letchuman R, Noraini N, Ropilah AR, Zainal M, Ismail IS, Wan Mohamad WB, Faridah I, Singaraveloo M, Sheriff IH, Khalid BA: Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics. Diabetes Res Clin Pract46 :213– 221,1999 .
  • Roberts WC: Recent studies on the effects of beta-blockers on blood lipid levels. Am Heart J117 :709– 714,1989 .
  • Pollare T, Lithell H, Selinus J, Berne C: Sensitivity to insulin during treatment with atenolol and propanolol: a randomized, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ298 :1152– 1157,1989 .
  • Jacques PF: Effects of vitamin C on high-density lipoprotein cholesterol and blood pressure. J Am Coll Nutr11 :139– 144,1992 .
  • Zozaya JL: Nutritional factors in high blood pressure. J Hum Hypertens14 :S100– S104,2000 .
  • Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR: Combination oral antioxidant supplementation reduces blood pressure. Clin Science92 :361– 365,1997
  • Mullan BA, Young IS, Fee H, McCance DR: Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension40 :789– 791,2002 .
  • Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ: Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetes. Clin Sci103 :339– 344,2002 .
  • Boshtam M, Rafiei M, Sadeghi K, Sarraf-Zadegan N: Vitamin E can reduce blood pressure in mild hypertensives. Int J Vitam Nutr Res72 :309– 314,2002 .
  • Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, Capra A, Rossi S, Nosotti L, Costantini C, Cavalera C: Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Am J Hypertens13 :564– 567,2000 .
  • Eriksson J, Kohvakka A: Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab39 :217– 223,1995 .
  • Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M: Relationship of serum and dietary magnesium to incidence hypertension: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol9 :159– 165,1999 .
  • Kawano Y, Matsuoka H, Takishita S, Omae T: Effects of magnesium supplementation in hypertension patients. Hypertension32 :260– 265,1998 .
  • Itoh K, Kawasaki T, Nakamura M: The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr78 :737– 750,1997 .
  • Doyle L, Flynn A, Cashman K: The effect of magnesium supplementation on biochemical markers of bone metabolism or blood pressure in healthy young adults females. Eur J Clin Nutr53 :255– 261,1999 .
  • Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ: Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension31 :131– 138,1998 .
  • Hamilton IMJ, Gilmore WS, Benzie IFF, Mulholland CW, Strain JJ: Interactions between vitamin C and E in human subjects. Br J Nutr84 :261– 267,2000 .
  • Zago MP, Oteiza PI: The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med31 :266– 274,2001 .
  • Meydani SN, Meydani M, Rall LC, Morrow F, Blumberg JB: Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. Am J Clin Nutr60 :704– 709,1994 .
  • Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G: Effects of vitamin E and glutathione on glucose metabolism, role of magnesium. Hypertension34(Part2) :1002– 1006,1999 .
  • Paolisso G, Tagliamonte MR, Barbieri M, Zito GA, Gambardella A, Varricchio G, Ragno E, Varricchio M: Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type 2 diabetic patients. J Clin Endocrinol Metab85 :109– 115,2000 .
  • Roe JH: Ascorbic acid. In Gyorgy P, Pearson WN (eds): “The Vitamins. Chemistry, Physiology, Pathology, Methods,” Vol. VI, 2nd ed. New York: Academic Press, pp27– 51,1967 .
  • Sanz DC, Santa-Cruz MC: Stimultaneous measurement of retinol and α-tocopherol in human serum by high-performance liquid chromatography with ultraviolet detection. J Chromatogr380 :140– 144,1986 .
  • Stol C: Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest17 :381– 387,1965 .
  • Satoh K: Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta90 :37– 43,1978 .
  • West JB: “Best and Taylor’s Physiological Basis of Medical Practice,” 12th ed. Baltimore: Williams & Wilkins, p146 ,1991 .
  • Hasslacher C: Hypertension as a risk factor in non-insulin dependent diabetes mellitus: How far should blood pressure be reduced? J Diabet Complicat11 :90– 91,1997 .
  • Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA276 :1886– 1892,1996 .
  • UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ317 :703– 712,1998 .
  • Marks JB, Raskin P: Nephropathy and hypertension in diabetes. Med Clin North Am82 :877– 879,1998 .
  • Hermansen K: Diet, blood pressure and hypertension. Br J Nutr83 :S113– S119,2000 .
  • Carr AC, Zhu BZ, Frei B: Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res87 :349– 354,2000 .
  • Rayssiguier Y, Durlach J, Gueux E, Rock E, Mazur A: Magnesium and ageing. I. Experimental data: importance of oxidative damage. Magnes Res6 :369– 378,1993 .
  • Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo’ A, Paolisso G: Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med24 :39– 52,2003 .
  • Tell GS, Rutan GH, Kronmal RA, Bild DE, Polak JF, Wong ND, Borhani NO: Correlates of blood pressure in community-dwelling older adults. The Cardiovascular Health Study. Cardiovascular Health Study (CHS) Collaborative Research Group. Hypertension23 :59– 67,1994 .
  • He J, Tell GS, Tang YC, Mo PS, He GQ: Relation of electrolytes to blood pressure in men. The Yi people study. Hypertension17 :378– 385,1991 .
  • Kesteloot H, Joossens JV: Relationship of serum sodium, potassium, calcium, and phosphorus with blood pressure. Belgian Interuniversity Research on Nutrition and Health. Hypertension12 :589– 593,1988 .
  • Yoshioka M, Mastsushita T, Chuman Y: Inverse association of serum ascorbic acid level and blood pressure or rate of hypertension in male adults aged 30–39 years. Int J Vitam Nutr Res54 :343– 347,1984 .
  • Skou JC: Enzymatic basis for active transport of Na+ and k+ across cell membrane. Physiol Rev45 :596– 617,1965 .
  • Palaty V: Regulation of the cell magnesium in vacular smooth muscle. J Physiol242 :555– 569,1974 .
  • Jee SH, Miller III ER, Guallar E, Singh VK, Apple LJ, Klag MJ: The effect of magnesium supplementation on blood pressure: A meta-analysis of randomized clinical trials. Am J Hypertens15 :691– 696,2002 .
  • Yusuf S, Sleight P, Pogue J: Effects of angiotensin-converting-anzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Events Study Investigators. New Engl J Med342 :145– 153,2000 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.